Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies
Clinical trial NCT03291379 · COMPLETED
Trial details
- NCT number
- NCT03291379
- Sponsor
- Boston Scientific Corporation
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-17
- Primary completion
- 2019-08-03
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.